HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Valeant drops name in bid to break with past

This article was originally published in OTC Bulletin & The Rose Sheet

Executive Summary

Bausch Health Companies will be the new name for Canada’s Valeant Pharmaceuticals International from 1 July 2018. The name – which is taken from the firm’s Bausch + Lomb eye-care business – “accurately represents the breadth of the company today”, according to Valeant, “and reflects the innovative legacy of the Bausch business”.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

RS122190

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel